vs
ICU MEDICAL INC（ICUI）与Regency Centers（REG）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Regency Centers的1.3倍（$540.7M vs $404.2M），Regency Centers净利率更高（50.1% vs -2.9%，领先53.0%），Regency Centers同比增速更快（8.5% vs -14.1%），过去两年Regency Centers的营收复合增速更高（5.4% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Regency Centers是总部位于美国佛罗里达州杰克逊维尔的房地产投资信托基金，也是以超市为核心租户的大型购物中心运营商之一。截至2020年10月21日，公司共持有415处物业，总建筑面积达5600万平方英尺，知名资产包括Serramonte Center及Village District 30%的股权。
ICUI vs REG — 直观对比
营收规模更大
ICUI
是对方的1.3倍
$404.2M
营收增速更快
REG
高出22.6%
-14.1%
净利率更高
REG
高出53.0%
-2.9%
两年增速更快
REG
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $404.2M |
| 净利润 | $-15.7M | $202.5M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 71.0% |
| 净利率 | -2.9% | 50.1% |
| 营收同比 | -14.1% | 8.5% |
| 净利润同比 | 34.0% | 134.1% |
| 每股收益（稀释后） | $-0.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIREG
| Q4 25 | $540.7M | $404.2M | ||
| Q3 25 | $537.0M | $387.6M | ||
| Q2 25 | $548.9M | $380.8M | ||
| Q1 25 | $604.7M | $380.9M | ||
| Q4 24 | $629.8M | $372.5M | ||
| Q3 24 | $589.1M | $360.3M | ||
| Q2 24 | $596.5M | $357.3M | ||
| Q1 24 | $566.7M | $363.9M |
净利润ICUIREG
| Q4 25 | $-15.7M | $202.5M | ||
| Q3 25 | $-3.4M | $109.4M | ||
| Q2 25 | $35.3M | $106.0M | ||
| Q1 25 | $-15.5M | $109.6M | ||
| Q4 24 | $-23.8M | $86.5M | ||
| Q3 24 | $-33.0M | $101.5M | ||
| Q2 24 | $-21.4M | $102.7M | ||
| Q1 24 | $-39.5M | $109.8M |
毛利率ICUIREG
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
营业利润率ICUIREG
| Q4 25 | 1.0% | 71.0% | ||
| Q3 25 | 2.6% | 72.7% | ||
| Q2 25 | 1.9% | 73.8% | ||
| Q1 25 | 2.1% | 71.8% | ||
| Q4 24 | 6.0% | 71.1% | ||
| Q3 24 | 1.4% | 72.5% | ||
| Q2 24 | 1.3% | 72.3% | ||
| Q1 24 | -1.9% | 72.3% |
净利率ICUIREG
| Q4 25 | -2.9% | 50.1% | ||
| Q3 25 | -0.6% | 28.2% | ||
| Q2 25 | 6.4% | 27.8% | ||
| Q1 25 | -2.6% | 28.8% | ||
| Q4 24 | -3.8% | 23.2% | ||
| Q3 24 | -5.6% | 28.2% | ||
| Q2 24 | -3.6% | 28.7% | ||
| Q1 24 | -7.0% | 30.2% |
每股收益（稀释后）ICUIREG
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $4.7B |
| 股东权益账面价值 | $2.1B | $6.9B |
| 总资产 | $4.1B | $13.0B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资ICUIREG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | — | ||
| Q2 24 | $302.6M | — | ||
| Q1 24 | $251.4M | — |
总债务ICUIREG
| Q4 25 | — | $4.7B | ||
| Q3 25 | — | $4.9B | ||
| Q2 25 | — | $4.8B | ||
| Q1 25 | — | $4.6B | ||
| Q4 24 | — | $4.4B | ||
| Q3 24 | — | $4.4B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.4B |
股东权益ICUIREG
| Q4 25 | $2.1B | $6.9B | ||
| Q3 25 | $2.1B | $6.8B | ||
| Q2 25 | $2.1B | $6.7B | ||
| Q1 25 | $2.0B | $6.7B | ||
| Q4 24 | $2.0B | $6.7B | ||
| Q3 24 | $2.0B | $6.8B | ||
| Q2 24 | $2.0B | $6.8B | ||
| Q1 24 | $2.1B | $7.0B |
总资产ICUIREG
| Q4 25 | $4.1B | $13.0B | ||
| Q3 25 | $4.1B | $13.1B | ||
| Q2 25 | $4.1B | $12.7B | ||
| Q1 25 | $4.2B | $12.6B | ||
| Q4 24 | $4.2B | $12.4B | ||
| Q3 24 | $4.3B | $12.4B | ||
| Q2 24 | $4.3B | $12.4B | ||
| Q1 24 | $4.3B | $12.7B |
负债/权益比ICUIREG
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | 0.65× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $203.9M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | — | 1.01× |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUIREG
| Q4 25 | $60.6M | $203.9M | ||
| Q3 25 | $56.7M | $218.7M | ||
| Q2 25 | $11.2M | $244.0M | ||
| Q1 25 | $51.3M | $161.0M | ||
| Q4 24 | $40.2M | $191.4M | ||
| Q3 24 | $36.1M | $227.6M | ||
| Q2 24 | $82.0M | $203.5M | ||
| Q1 24 | $45.8M | $167.8M |
自由现金流ICUIREG
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | — | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUIREG
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUIREG
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.8% | — |
现金转化率ICUIREG
| Q4 25 | — | 1.01× | ||
| Q3 25 | — | 2.00× | ||
| Q2 25 | 0.32× | 2.30× | ||
| Q1 25 | — | 1.47× | ||
| Q4 24 | — | 2.21× | ||
| Q3 24 | — | 2.24× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
REG
| Shopping Centers | $418.0M | 103% |
| Propertymanagementservices | $4.1M | 1% |
| Assetmanagementservices | $1.7M | 0% |
